ask="N/A"
ask_size="N/A"
average_daily_volume="1917500"
bid="N/A"
bid_size="N/A"
book_value="-0.1510"
change="-0.0019"
change_from_200_day_moving_average="-0.1304"
change_from_50_day_moving_average="0.0172"
change_from_52_week_high="-0.5949"
change_From_52_week_low="0.1551"
change_in_percent="-0.4556%"
close="0.4151"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="0.4640"
ebitda="-30.10M"
eps_estimate_current_year="-0.3800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.3200"
ex_dividend_date="N/A"
float_shares="71869000"
high="0.4391"
high_52_weeks="1.0100"
last_trade_date="1/5/2017"
last_trade_price="0.4151"
last_trade_size="350"
last_trade_time="4:45pm"
low="0.4100"
low_52_weeks="0.2600"
market_capitalization="41.44M"
moving_average_200_day="0.5455"
moving_average_50_day="0.3979"
name="Protalix BioTherapeutics
Inc. "
notes="N/A"
one_year_target_price="2.4000"
open="0.4200"
pe_ratio="0.8946"
peg_ratio="-0.0500"
percent_change_from_200_day_moving_average="-23.9057%"
percent_change_from_50_day_moving_average="+4.3282%"
percent_change_from_52_week_high="-58.9010%"
percent_change_from_52_week_low="+59.6539%"
previous_close="0.4170"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="5.8479"
revenue="7.12M"
shares_outstanding="99821000"
short_ratio="0.1000"
stock_exchange="ASE"
symbol="PLX"
volume="1541057"
weeks_range_52="0.2600 - 1.0100"
